CClinicalTrials.gg
Status unknownNCT03040219Updated Mar 14, 2017

Folic Acid Supplementation as an Appetizer in Primary Malnourished Egyptian Infants and Children

A Phase 4 interventional study of Folic Acid in Primary Malnurtrition, sponsored by Ain Shams University. Status unknown at 1 site in Egypt. Open to participants aged 2 Years to 6 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2017-03-14.

Sponsored by Ain Shams University · Phase 4, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Mar 2017), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Phase 4
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
2 Years to 6 Years
Sex
All
01

Study summary

Folic acid as a appetizer in primary malnutrition

02

Conditions studied

  • Primary Malnurtrition

Browse trials for

03

In context

Malnutrition

1,587 studies on the registry are indexed under Malnutrition; 237 are open to participants now.

This study's planned enrollment of 100 is above the median of 90 across 1,134 interventional studies indexed under Malnutrition.

Browse Malnutrition studies →

Lead sponsor

Ain Shams University is the lead sponsor of 1,876 studies on the registry; 423 are open to participants now.

Of its 32 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
2 Years to 6 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

Primary malnourished children

Exclusion criteria

Exclusion Criteria:

  • previous folic supplementation in the past 3 months
05

Study design

Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
100 participants (estimated)

Study arms

  • Active comparator
    Treatment group

    Drug: Folic Acid

  • Placebo comparator
    Control

    Drug: Folic Acid

Interventions

  • DrugFolic Acid

    Tablets

06

What researchers measure

Primary outcomes

  1. Appetite

    Child eating behaviour questionnaire

    Time frame: Through study completion_ after 3 months from start of supplementation

Secondary outcomes

  1. Leptin and ghrelin hormone

    Serum level

    Time frame: 3 months

Other outcomes

  1. Growth

    Anthropometric study

    Time frame: Through study completion -after 3 months from start of supplementation

07

Study locations

1 site
  • Marian girgis
    Cairo, Egypt
    • Marian Girgis · Contact
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 14, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03040219
Lead sponsor
Ain Shams University
Responsible party
Marian girgis (Principal investigator, Ain Shams University) — Principal investigator
First posted
Feb 2, 2017
Start date
Apr 1, 2017 (estimated)
Primary completion
Nov 1, 2017 (estimated)
Completion
Dec 1, 2017 (estimated)
Last update
Mar 14, 2017

Study contacts

Marian Girgis
Contact
Mariangirgis2009@yahoo.com
0201223646224
Marian Girgis
principal investigator · Ain Shams University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
Yes
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Mar 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion